Position in ZTS
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$1,509
-$3,228 QoQ
Shares Held
21
-25.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1,355
of 1,412 holders
Holding Since
Mar 2023
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Creative Capital Management Investments LLC holds $25,031 across 12 Drug Manufacturers - Specialty & Generic names. ZTS ranks #6 (6.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
361 | $5,732 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
10 | $5,418 | |
| 3 | ELAN |
Elanco Animal Health Inc
|
149 | $3,666 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
19 | $3,202 | |
| 5 | ALKS |
Alkermes plc.
|
37 | $1,938 | |
| 6 | ZTS |
Zoetis Inc.
This page
|
21 | $1,509 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
12 | $1,331 | |
| 8 | AMRX |
Amneal Pharmaceuticals, Inc.
|
45 | $778 |
All Filings in ZTS
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,509 | 21 | Shares | Sole | 2026-07-24 | |
| 2024-03-31 | $4,737 | 28 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $5,526 | 28 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $4,871 | 28 | Shares | Sole | 2024-04-22 | |
| 2023-06-30 | $4,821 | 28 | Shares | Sole | 2024-04-22 | |
| 2023-03-31 | $4,660 | 28 | Shares | Sole | 2024-04-22 | |
| No filing history on record for this holder in this stock. | ||||||